Literature DB >> 28689731

Surgical management of primary hyperparathyroidism: A single-center experience.

David Kwan-Ru Huang1, Fong-Fu Chou2, Shun-Yu Chi3, Yi-Chia Chan3, Shun-Chen Huang4.   

Abstract

BACKGROUND: Primary hyperparathyroidism (PHPT) can occur at any age. This study aimed to compare the necessity, feasibility, safety, and outcomes of parathyroidectomy in the management of minor-symptomatic or asymptomatic PHPT patients according to age (young vs. old).
METHODS: We retrospectively reviewed the medical records of 146 consecutive patients who underwent surgery for PHPT from January 2005 to June 2016 in our institution. The patients ranged in age from 12 to 85 years. For the analysis, the included patients (n = 137) were separated into young (age <50 years; n = 31, 22.6%) and old (age ≥50 years; n = 106, 77.4%) patients. The biochemical characteristics (parathyroid hormone, calcium, and creatinine levels), T-score of bone densitometry, surgical reports, pathology reports, perioperative intensive care unit care, and 30-day mortality were reviewed.
RESULTS: The average medical treatment course after diagnosis tended to be longer in the old group (33.3 vs. 26.2 weeks, p = 0.62). During the medical treatment course, the old group had a higher risk of developing new symptoms or severe complications (5.6% vs. 3.2%, p = 0.05), and the older patients seemed to have a longer postoperative hospitalization (p = 0.17). However, there were no significant differences in the 30-day mortality, immediate complications, and follow-up duration.
CONCLUSION: In older patients, surgical treatment of PHPT is safe and feasible, with comparable outcomes to in younger patients, and helps prevent the development or progression of symptoms and complication. Hence, parathyroidectomy should be the recommended treatment and should be performed in PHPT patients as early as possible, regardless their age and initial symptoms.
Copyright © 2017. Published by Elsevier Taiwan LLC.

Entities:  

Keywords:  Asymptomatic; Parathyroidectomy; Primary hyperparathyroidism

Mesh:

Year:  2017        PMID: 28689731     DOI: 10.1016/j.asjsur.2017.05.001

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  1 in total

1.  Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.

Authors:  Ying Wei; Lili Peng; Yan Li; Zhen Long Zhao; Ming An Yu
Journal:  Korean J Radiol       Date:  2020-05       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.